Ovarian cancer presents significant challenges due to its tumor microenvironment—a complex network of cells, molecules, and ...

Emily Bond, then 37, noticed a slight difference in her nipple and visited her doctor. She later learned had Stage 2 breast ...

By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for ...

A University of Iowa research team led by Jill Kolesar, UI College of Pharmacy dean and professor, has received an $8.8 ...

Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer, which does ...

Scientists say the Royal Marsden hospitals' drug trial could change practice globally for serous form of ovarian cancer which ...

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

Experts are so excited by the latest findings that they hope the treatment will change practice globally for this type of ...

This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other solid tumor types. From Ann Wilson’s return to Heart after chemotherapy to ...

Ovarian cancer caused the highest cancer-related mortality among female reproductive system malignancies. Platinum-based chemotherapy is still the footstone of the chemotherapy for ovarian cancer.

‘Response rate’ means the proportion of patients whose tumours shrank following treatment. The trials they used in the study ...

Scientists have been awarded funding to create the world’s first ovarian cancer vaccine. OvarianVax, is a vaccine that will ...